DK146962C - Analogifremgangsmaade til fremstilling af indolizinderivater - Google Patents

Analogifremgangsmaade til fremstilling af indolizinderivater

Info

Publication number
DK146962C
DK146962C DK291180A DK291180A DK146962C DK 146962 C DK146962 C DK 146962C DK 291180 A DK291180 A DK 291180A DK 291180 A DK291180 A DK 291180A DK 146962 C DK146962 C DK 146962C
Authority
DK
Denmark
Prior art keywords
preparation
analogy procedure
indolizin
derivatives
indolizin derivatives
Prior art date
Application number
DK291180A
Other languages
English (en)
Other versions
DK146962B (da
DK291180A (da
Inventor
Gilbert Rosseels
Pierre Nokin
Original Assignee
Labaz Sanofi Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Labaz Sanofi Nv filed Critical Labaz Sanofi Nv
Publication of DK291180A publication Critical patent/DK291180A/da
Publication of DK146962B publication Critical patent/DK146962B/da
Application granted granted Critical
Publication of DK146962C publication Critical patent/DK146962C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
DK291180A 1979-07-06 1980-07-04 Analogifremgangsmaade til fremstilling af indolizinderivater DK146962C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7923599 1979-07-06
GB7923599 1979-07-06

Publications (3)

Publication Number Publication Date
DK291180A DK291180A (da) 1981-01-07
DK146962B DK146962B (da) 1984-02-27
DK146962C true DK146962C (da) 1984-08-06

Family

ID=10506339

Family Applications (1)

Application Number Title Priority Date Filing Date
DK291180A DK146962C (da) 1979-07-06 1980-07-04 Analogifremgangsmaade til fremstilling af indolizinderivater

Country Status (24)

Country Link
US (1) US4400387A (da)
EP (1) EP0022762B1 (da)
JP (1) JPS5618979A (da)
AR (1) AR225314A1 (da)
AT (1) AT375078B (da)
AU (1) AU529725B2 (da)
CA (1) CA1153379A (da)
DD (1) DD151940A5 (da)
DE (1) DE3060097D1 (da)
DK (1) DK146962C (da)
ES (1) ES8105710A1 (da)
FI (1) FI67217C (da)
GR (1) GR69280B (da)
HU (1) HU182151B (da)
IE (1) IE49994B1 (da)
IN (1) IN151594B (da)
NO (1) NO153496C (da)
NZ (1) NZ193926A (da)
OA (1) OA06563A (da)
PL (1) PL125597B1 (da)
PT (1) PT71424A (da)
SU (1) SU993817A3 (da)
YU (1) YU171880A (da)
ZA (1) ZA803434B (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6103702A (en) * 1999-05-24 2000-08-15 Board Of Trustees Of The University Of Illinois Use of adenosine deaminase inhibitors to treat systemic inflammatory response syndrome
WO2001007054A1 (en) * 1999-07-22 2001-02-01 Supergen, Inc. Methods for treating autoimmune diseases
FR2805460A1 (fr) * 2000-02-25 2001-08-31 Oreal Compositions de teinture des fibres keratiniques contenant des derives d'indolizine cationiques et procede de teinture
FR2838123B1 (fr) * 2002-04-04 2005-06-10 Sanofi Synthelabo Nouveaux derives d'indolozine-1,2,3 substituee, inhibiteurs selectifs du b-fgf
JP4048166B2 (ja) * 2002-11-18 2008-02-13 三井製糖株式会社 血糖値上昇抑制剤及び体脂肪蓄積抑制剤並びに食用材料
FR2859997B1 (fr) * 2003-09-18 2006-02-03 Sanofi Synthelabo Nouveaux derives d'indolizine 1,2,3,6,7,8 substituee, inhibiteurs des fgfs, leur procede de preparation et les compositions pharmaceutiques les contenant.
AR051780A1 (es) * 2004-11-29 2007-02-07 Japan Tobacco Inc Compuestos en anillo fusionados que contienen nitrogeno y utilizacion de los mismos
FR2896247B1 (fr) 2006-01-13 2008-02-29 Sanofi Aventis Sa Composes dimeres agonistes des recepteurs des fgfs (fgfrs), leur procede de preparation et leur application en therapeutique
CA2755132C (en) 2009-03-31 2018-02-13 Kissei Pharmaceutical Co., Ltd. Indolizine derivative and use thereof for medical purposes
US20100261666A1 (en) * 2009-04-14 2010-10-14 The Board Of Trustees Of The University Of Illinois Compositions and methods for the treatment of myocardial dysfunction associated with sirs or sepsis
WO2012043638A1 (ja) * 2010-09-29 2012-04-05 キッセイ薬品工業株式会社 (アザ)インドリジン誘導体及びその医薬用途
CA2998034C (en) * 2015-09-10 2021-05-04 Dongfang Shi A group of compounds used for the treatment or prevention of hyperuricemia or gout
CN108084186B (zh) 2016-11-16 2021-06-25 江苏新元素医药科技有限公司 Urat1抑制剂及其应用
WO2018090921A1 (zh) 2016-11-16 2018-05-24 江苏新元素医药科技有限公司 Urat1抑制剂及其应用
ES2912941T3 (es) * 2017-05-26 2022-05-30 Jiangsu Atom Bioscience And Pharmaceutical Co Ltd Inhibidores de URAT1 para promover la excreción de ácido úrico
CN108727267B (zh) * 2017-05-26 2022-05-13 江苏新元素医药科技有限公司 一类urat1抑制剂及其应用
JP7266901B2 (ja) * 2018-01-19 2023-05-01 エボポイント、バイオサイエンシズ、カンパニー、リミテッド 複素環式化合物、調製方法及びその医薬的な応用
CN110283167A (zh) * 2018-11-14 2019-09-27 贵州省中国科学院天然产物化学重点实验室 一种抗心率失常药物布托普洛嗪的制备方法
WO2022169974A1 (en) 2021-02-05 2022-08-11 Nexys Therapeutics, Inc. Inhibitors of urat1 and pharmaceutical uses thereof
WO2023221078A1 (en) * 2022-05-20 2023-11-23 Jiangsu Atom Bioscience And Pharmaceutical Co., Ltd. Solid forms of a compound for treating or preventing hyperuricemia or gout

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU430639A1 (ru) 1972-06-05 1978-02-28 Московский Ордена Ленина И Ордена Трудового Красного Знамени Государственный Университет Им.М.В.Ломоносова Способ получени 1-пиридилиндолизинов
GB1518443A (en) * 1976-02-19 1978-07-19 Labaz Indolizine derivatives and process for preparing the same
FI61030C (fi) 1976-02-19 1982-05-10 Sanofi Sa Foerfarande foer framstaellning av terapeutiskt verkande 2-substituerade-1- eller 3-benzoyl-indolizinderivat

Also Published As

Publication number Publication date
ES493139A0 (es) 1981-06-16
NO153496C (no) 1986-05-14
YU171880A (en) 1983-10-31
ZA803434B (en) 1981-05-27
EP0022762A1 (fr) 1981-01-21
HU182151B (en) 1983-12-28
PL125597B1 (en) 1983-05-31
FI67217C (fi) 1985-02-11
FI67217B (fi) 1984-10-31
AT375078B (de) 1984-06-25
SU993817A3 (ru) 1983-01-30
DK146962B (da) 1984-02-27
US4400387A (en) 1983-08-23
AU5948780A (en) 1981-01-15
FI802165A (fi) 1981-01-07
PL225479A1 (da) 1981-10-30
NO153496B (no) 1985-12-23
IN151594B (da) 1983-06-04
JPS5618979A (en) 1981-02-23
DE3060097D1 (en) 1982-01-28
OA06563A (fr) 1981-07-31
DD151940A5 (de) 1981-11-11
AU529725B2 (en) 1983-06-16
PT71424A (en) 1980-07-01
DK291180A (da) 1981-01-07
IE801349L (en) 1981-01-06
AR225314A1 (es) 1982-03-15
EP0022762B1 (fr) 1981-11-25
ATA354380A (de) 1983-11-15
NO802015L (no) 1981-01-07
NZ193926A (en) 1984-05-31
CA1153379A (en) 1983-09-06
ES8105710A1 (es) 1981-06-16
IE49994B1 (en) 1986-01-22
GR69280B (da) 1982-05-13

Similar Documents

Publication Publication Date Title
DK546080A (da) Fremgangsmaade til fremstilling af galactosaccharosederivater
DK158225C (da) Analogifremgangsmaade til fremstilling af carbostyrilderivater
DK365280A (da) Fremgangsmaade til fremstilling af ftaliminderivater
DK148280C (da) Analogifremgangsmaade til fremstilling af thienothiazinderivater
DK155367C (da) Analogifremgangsmaade til fremstilling af 2-nitroimidazolderivater
DK29681A (da) Fremgangsmaade til fremstilling af immunogammaglobulin
DK311580A (da) Fremgangsmaade til fremstilling af oxoalkylxanthiner
DK155669C (da) Analogifremgangsmaade til fremstilling af pleuromutilinderivater
DK146962C (da) Analogifremgangsmaade til fremstilling af indolizinderivater
DK158984C (da) Analogifremgangsmaade til fremstilling af carbostyrilderivater
DK274580A (da) Fremgangsmaade til fremstilling af tripeptidamider
DK149623C (da) Fremgangsmaade til fremstilling af alfa-hydroxycarboxylsyreamider
DK552180A (da) Fremgangsmaade til fremstilling af tetrapeptidsemikarbazidderivater
DK153791C (da) Fremgangsmaade til fremstilling af 7-hydroxycumaraner
DK153482C (da) Analogifremgangsmaade til fremstilling af 5-cyano-prostacyklinderivater
DK156643C (da) Analogifremgangsmaade til fremstilling af naphthalensulfonamidderivater
DK154137C (da) Analogifremgangsmaade til fremstilling af meta-sulfonamido-benzamidderivater
DK147795C (da) Analogifremgangsmaade til fremstilling af xanthinderivater
DK187980A (da) Fremgangsmaade til fremstilling af benzimidazolderivater
DK154650C (da) Analogifremgangsmaade til fremstilling af sukkerderivater
DK262180A (da) Fremgangsmaade til fremstilling af alkyl-2-chlorpropionater
DK53780A (da) Fremgangsmaade til fremstilling af cephalosporinderivater
DK274680A (da) Fremgangsmaade til fremstilling af tripeptidamider
DK222880A (da) Fremgangsmaade til fremstilling af anthracyclinonderivater
DK304080A (da) Fremgangsmaade til fremstilling af pyrazoloindazolderivater

Legal Events

Date Code Title Description
PBP Patent lapsed